PCM
Polaris Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,620,978
| Closed | -$24.2M | – | 84 |
|
|
2019
Q2 | $24.2M | Sell |
2,620,978
-7,590,602
| -74% | -$70.1M | 1.02% | 30 |
|
|
2019
Q1 | $160M | Sell |
10,211,580
-131,400
| -1% | -$2.06M | 6.66% | 5 |
|
|
2018
Q4 | $159M | Buy |
10,342,980
+431,942
| +4% | +$6.66M | 7.31% | 5 |
|
|
2018
Q3 | $213M | Buy |
9,911,038
+817,964
| +9% | +$17.6M | 9.3% | 1 |
|
|
2018
Q2 | $221M | Sell |
9,093,074
-731,200
| -7% | -$17.8M | 10.23% | 1 |
|
|
2018
Q1 | $168M | Buy |
9,824,274
+897,368
| +10% | +$15.3M | 6.19% | 4 |
|
|
2017
Q4 | $169M | Buy |
8,926,906
+4,939,569
| +124% | +$93.6M | 7.91% | 2 |
|
|
2017
Q3 | $70.2M | Buy |
3,987,337
+560,200
| +16% | +$9.86M | 3.92% | 5 |
|
|
2017
Q2 | $114M | Buy |
3,427,137
+1,326,990
| +63% | +$44.1M | 6.7% | 5 |
|
|
2017
Q1 | $67.4M | Buy |
2,100,147
+135,400
| +7% | +$4.35M | 4.79% | 4 |
|
|
2016
Q4 | $71.2M | Buy |
1,964,747
+171,400
| +10% | +$6.21M | 4.6% | 5 |
|
|
2016
Q3 | $82.5M | Sell |
1,793,347
-34,337
| -2% | -$1.58M | 6.42% | 5 |
|
|
2016
Q2 | $91.8M | Buy |
1,827,684
+53,600
| +3% | +$2.69M | 7.98% | 4 |
|
|
2016
Q1 | $96.6M | Sell |
1,774,084
-27,075
| -2% | -$1.47M | 8.3% | 3 |
|
|
2015
Q4 | $118M | Buy |
1,801,159
+89,828
| +5% | +$5.9M | 11.97% | 1 |
|
|
2015
Q3 | $96.6M | Buy |
1,711,331
+31,400
| +2% | +$1.77M | 11.7% | 2 |
|
|
2015
Q2 | $99.3M | Buy |
1,679,931
+34,200
| +2% | +$2.02M | 12.18% | 1 |
|
|
2015
Q1 | $103M | Sell |
1,645,731
-130,200
| -7% | -$8.11M | 14.32% | 1 |
|
|
2014
Q4 | $102M | Buy |
+1,775,931
| New | +$102M | 17.12% | 1 |
|